Returning to endoscopy normality through the support of a new non-invasive faecal test based on microbial signatures.

Malagón, M; Oliver, L; Ramió-Pujol, S; Guardiola, J; Balaguer, F

Malagón, M; Oliver, L; Ramió-Pujol, S; Guardiola, J; Balaguer, F.

Malagón M; GoodGut S.L., Girona, Spain.
Oliver L; GoodGut S.L., Girona, Spain.
Ramió-Pujol S; GoodGut S.L., Girona, Spain.
Guardiola J; Digestive Diseases Department, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
Balaguer F; Department of Gastroenterology, Hospital Clínic Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain. Electronic address: fprunes@clinic.cat

Dig Liver Dis ; 53(12): 1666-1668, 2021 12.

Article in English | MEDLINE | ID: covidwho-1391393

Subject(s)

Colonoscopy; Occult Blood; Humans

Keywords

Bacterial markers; COVID-19; Colorectal cancer screening; Faecal immunochemical test; Intestinal microbiota; in vitro diagnosis; qPCR

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colonoscopy / Occult Blood Limits: Humans Language: English Journal: Dig Liver Dis Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: J.dld.2021.08.006

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google